Big Gain For IMV Inc.

Tue 14 Jul 20 at 05:30 PM
Big Gain For IMV Inc.

IMV Inc. (IMV:NASDAQ) soared at $4.63, representing a gain of 54.3%. The stock got featured on our News Catalysts scanner on Tue 14 Jul 20 at 02:19 PM in the 'BIOTECH' category. From Mon 29 Jun 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Thu 21 May 20 at $4 with a volume of 2M+, and its share price has been moving sideways in recent weeks.


Immunovaccine Inc is a Canada based clinical-stage biopharmaceutical company. Through its subsidiary, the firm develops T cell activating cancer immunotherapies and infectious disease vaccines based on DepoVax.